Skip to main content

Table 1 Patient characteristics

From: The Paris System for reporting urinary cytology improves the negative predictive value of high-grade urothelial carcinoma

Variables

 

CS (n = 560)

TPS (n = 89)

P values*

Mean age

Years (range)

73.1 (31–100)

73.5 (26–93)

0.39

Sex

 Male

No. (%)

487 (87.0)

77 (86.5)

0.91

 Female

No. (%)

73 (13.0)

12 (13.5)

Prior recurrence status

 Primary

No. (%)

339 (60.5)

68 (76.4)

< 0.01

 Recurrent

No. (%)

221 (39.5)

21 (23.6)

Prior TUR within 90 days

 Yes

No. (%)

82 (14.6)

27 (30.3)

< 0.01

 No

No. (%)

478 (85.4)

62 (69.7)

Tumor appearance

 Papillary

No. (%)

478 (85.4)

78 (87.6)

0.57

 Solid

No. (%)

82 (14.6)

11 (12.4)

Tumor number

 Solitary

No. (%)

389 (69.5)

58 (65.1)

0.42

 Multiple

No. (%)

171 (30.5)

31 (34.9)

Largest tumor diameter

 < 3 cm

No. (%)

532 (95.0)

80 (89.9)

0.05

 ≥ 3 cm

No. (%)

28 (5.0)

9 (10.1)

High-grade tumor

 Yes

No. (%)

313 (55.9)

42 (47.2)

0.13

 No

No. (%)

247 (44.1)

47 (52.8)

Pathological tumor stage (Benign vs pT+)

 Benign

No. (%)

108 (19.2)

25 (28.1)

0.06

 pTis

No. (%)

49 (8.8)

8 (9.0)

 pTa

No. (%)

243 (43.4)

31 (34.8)

 pT1

No. (%)

117 (20.9)

16 (18.0)

 ≥ pT2

No. (%)

43 (7.7)

9 (10.1)

Concomitant CIS

 Yes

No. (%)

120 (21.4)

18 (20.2)

0.79

 No

No. (%)

440 (78.6)

71 (79.8)

  1. CS conventional systems, TPS The Paris System, TUR transurethral resection, CIS carcinoma in situ
  2. *P values were estimated using using the Mann–Whitney U test or the Fisher’s exact test